Conditions: Fibrillation, Atrial
Keywords: Cardioversion, Electric Pathological Conditions, Sings and Symptoms Cardiovascular Diseases Heart Diseases Atrial Fibrillation Arrhythmias, Cardiac Pathologic Processes Anticoagulants
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 349
Healthy volunteers: no

Brief summary:
The purpose of this study is to test whether Fondaparinux is effective and safe to prevent thromboembolic events (like for example strokes) and bleeding events in patients who undergo a normalisation of their heart rhythm disturbance. Fondaparinux will be compared with Heparin and tablets containing Vitamin-K-Antagonists (Phenprocoumon, Fluindione, or Warfarin).

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: fondaparinux intervention 2: unfractionated heparin intervention 3: Vitamin-K-Antagonist
Intervention descriptions: intervention 1: Comparison of different drugs intervention 2: Comparison of different drugs intervention 3: Comparison of different drugs

Protocol document: